1. Articles from biospace.com

  2. 49-61 of 61 « 1 2 3
    1. Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors

      Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors

      Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced the appointment of Lesley Russell, MBChB, MRCPb, to its Board of Directors. Dr. Russell will also serve as a member of Enanta’s audit committee and its nominating and corporate governance committee, effective as of January 1, 2017 ...

      Read Full Article
    2. Synthetic Genomics, Inc. Appoints Tina Nova, Ph.D., And William McKee To Board Of Directors

      Synthetic Genomics, Inc. Appoints Tina Nova, Ph.D., And William McKee To Board Of Directors

      Synthetic Genomics, Inc., announced today that it has appointed industry veterans Tina Nova , Ph.D., and William McKee to its board of directors. "Tina and Bill have decades of experience growing dynamic commercial organizations in new markets within the pharmaceutical and healthcare diagnostics industries," said Oliver Fetzer , Ph.D., chief executive officer of Synthetic Genomics ...

      Read Full Article
    3. PerkinElmer Elects Samuel R. Chapin to Board of Directors

      PerkinElmer Elects Samuel R. Chapin to Board of Directors

      PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that Samuel R. Chapin has been elected to the Company’s Board of Directors. "I am pleased to welcome Samuel to our Board, as he brings extensive experience in strategic advisory, mergers and acquisitions ...

      Read Full Article
    4. Nordic Nanovector Announces The Appointment Of Joanna Horobin, MD As Non-Executive Board Director

      Nordic Nanovector Announces The Appointment Of Joanna Horobin, MD As Non-Executive Board Director

      Ms Horobin has comprehensive experience within the biopharmaceutical industry. She is currently Senior Vice President, Chief Medical Officer and a Member of the Leadership Team at Idera Pharmaceuticals, Inc. in Cambridge, MA, USA. Ms Horobin’s current role includes the development and regulatory strategy as well as the execution of the clinical trial programme for the company's ...

      Read Full Article
    5. Deciphera Expands Board With Appointment Of Two New Directors

      Deciphera Expands Board With Appointment Of Two New Directors

      Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing tumor-targeted and immuno-targeted advanced kinase inhibitors, announced today that it has elected Edward J. Benz, Jr., M.D., and Patricia L. Allen to its Board of Directors. Dr. Benz is the outgoing President and Chief Executive Officer of the ...

      Read Full Article
    6. TearScience, Inc. Names To Board Of Directors

      TearScience, Inc. Names To Board Of Directors

      View More Jobs MORRISVILLE, N.C. , Aug. 8, 2016 /PRNewswire/ -- TearScience, a privately held medical device company and manufacturer of LipiScan, LipiView ® II and LipiFlow ® , today announced the addition of Edward J. Holland , MD, to its Board of Directors. "TearScience has shifted the perception of dry eye among eye care professionals (ECP's) to a proactive approach. TearScience technology offers an unparalleled ability to visualize and image the meibomian glands.....

      Read Full Article
    49-61 of 61 « 1 2 3
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content